Literature DB >> 27030925

The DoD Global, Laboratory-based, Influenza Surveillance Program: summary for the 2013-2014 influenza season.

Laurie S DeMarcus, Tiffany A Parms, Jeffrey W Thervil.   

Abstract

This report for the 2013-2014 influenza season summarizes the results of influenza surveillance carried out by the DoD Global, Laboratory-based, Influenza Surveillance Program, which is managed by the U.S. Air Force School of Aerospace Medicine Epidemiology Consult Service and Epidemiology Laboratory at Wright-Patterson Air Force Base, OH. Sentinel sites submitted 3,903 specimens for clinical diagnostic testing and 1,163 (29.8%) were positive for influenza virus. The predominant influenza subtype was influenza A(H1N1)pdm09, identified in 79.2% of all influenza-positive specimens. The other most common subtypes were influenza A(H3N2) (10.5%) and influenza B (10.1%). In August 2014, a human case of influenza A(H3N2) variant was identified in a patient with a history of exposure to swine. Adjusted vaccine effectiveness (VE) was calculated among 1,016 military dependents and retirees in the U.S. and was found to be 44.8% for all vaccine types. Uncertainties and other limitations associated with estimating VE are discussed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27030925

Source DB:  PubMed          Journal:  MSMR        ISSN: 2152-8217


  4 in total

1.  Post-pandemic influenza-associated mortality in Mexico.

Authors:  Jack N Salto-Quintana; Gerardo Rivera-Alfaro; Evelyn L Sánchez-Ramos; Alejandro Gómez-Gómez; Daniel E Noyola
Journal:  Pathog Glob Health       Date:  2019-03-21       Impact factor: 2.894

2.  Live Attenuated and Inactivated Influenza Vaccine Effectiveness.

Authors:  Jessie R Chung; Brendan Flannery; Christopher S Ambrose; Rodolfo E Bégué; Herve Caspard; Laurie DeMarcus; Ashley L Fowlkes; Geeta Kersellius; Andrea Steffens; Alicia M Fry
Journal:  Pediatrics       Date:  2019-01-07       Impact factor: 7.124

3.  Establishment and evaluation of a theater influenza monitoring platform.

Authors:  Jian Wang; Hui-Suo Yang; Bing Deng; Meng-Jing Shi; Xiang-Da Li; Qing-Gong Nian; Wen-Jing Song; Feng Bing; Qing-Feng Li
Journal:  Mil Med Res       Date:  2017-11-20

4.  Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) - United States, 2018-19 Influenza Season.

Authors:  Lisa A Grohskopf; Leslie Z Sokolow; Alicia M Fry; Emmanuel B Walter; Daniel B Jernigan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-06-08       Impact factor: 17.586

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.